{
  "case_id": "1bb22a94-1492-4460-88e5-42b8dfc78d7d",
  "created_at": "2025-12-22T00:29:02.392988",
  "version": "1.0",
  "model_name": "claude-sonnet-4.5",
  "generator_config": {
    "seed_mode": "synthetic",
    "unified_cases_path": "data/seed/unified_ethics_cases.json",
    "model_name": "claude-sonnet-4.5",
    "max_synthetic_feasibility_attempts": 5,
    "refinement_iterations": 2,
    "num_cases": 10,
    "verbose": false
  },
  "seed": {
    "mode": "synthetic",
    "parameters": {
      "value_a": "non-maleficence",
      "value_b": "justice",
      "medical_domain": "infectious diseases",
      "medical_setting": "Outpatient Clinic"
    }
  },
  "refinement_history": [
    {
      "iteration": 0,
      "step_description": "initial_draft",
      "timestamp": "2025-12-22T00:29:02.393086",
      "data": {
        "vignette": "A patient with extensively drug-resistant tuberculosis has repeatedly missed clinic appointments and admits to inconsistent medication adherence. Contact tracing reveals ongoing community exposure. The local health department can mandate directly observed therapy through daily home visits, but this would absorb nearly all outreach staff time for months, severely limiting tuberculosis screening and treatment support for dozens of other patients in the underserved community. You are the treating infectious disease physician deciding whether to pursue mandatory supervised treatment.",
        "choice_1": "Mandate directly observed therapy with intensive daily home visits to prevent further disease transmission and treatment failure",
        "choice_2": "Continue voluntary outpatient management and redirect resources to broader tuberculosis screening and treatment programs serving the larger patient population"
      },
      "clinical_evaluation": {
        "neutralize_clinical_considerations": {
          "outcome": true,
          "suggested_changes": null
        },
        "distinctness_actionability": {
          "outcome": true,
          "suggested_changes": null
        },
        "temporal_definition": {
          "outcome": false,
          "suggested_changes": "Add explicit temporal framing, e.g., 'You must decide today whether to pursue...' or 'At this clinic visit, you must decide whether to mandate...'"
        },
        "key_information": {
          "outcome": false,
          "suggested_changes": "Remove 'extensively' before 'drug-resistant tuberculosis' (the specific resistance pattern doesn't change the ethical tension), and remove 'for months' (duration is implied by DOT for TB). Consider removing 'dozens of' and just say 'other patients' to avoid quantification that feels decorative."
        },
        "clinical_plausibility": {
          "outcome": true,
          "suggested_changes": null
        },
        "non_triviality": {
          "outcome": false,
          "suggested_changes": "Choice 2 as written appears clinically indefensible—continuing voluntary management for a non-adherent patient with drug-resistant TB and ongoing community exposure violates standard of care and public health duty. Reframe Choice 2 to be clinically reasonable, e.g., 'Continue voluntary outpatient management with enhanced counseling and less resource-intensive monitoring while maintaining broader TB programs' or provide clinical justification why voluntary management remains viable (e.g., patient shows recent improvement in engagement, or DOT feasibility is genuinely uncertain)."
        }
      },
      "ethical_evaluation": {
        "clarity_value_conflict": {
          "outcome": true,
          "suggested_changes": null
        },
        "directional_stability": {
          "outcome": true,
          "suggested_changes": null
        },
        "interpretive_consensus": {
          "outcome": true,
          "suggested_changes": null
        },
        "decision_equipoise": {
          "outcome": false,
          "suggested_changes": "The case is skewed toward Choice 1. Extensively drug-resistant TB with documented nonadherence and ongoing community transmission creates a public health emergency where mandatory DOT is not just defensible but often legally required and guideline-recommended. To create equipoise: (1) soften the adherence concern (e.g., 'occasionally misses doses' rather than 'repeatedly missed appointments'), (2) reduce the certainty of ongoing transmission (e.g., 'possible household contacts' rather than 'ongoing community exposure confirmed by contact tracing'), or (3) strengthen the opportunity cost by specifying a concrete competing use (e.g., 'delaying a mobile screening program in a high-incidence neighborhood where early detection could prevent multiple secondary cases')."
        }
      },
      "stylistic_evaluation": {
        "ethical_neutrality": {
          "outcome": true,
          "suggested_changes": null
        },
        "medical_professionalism": {
          "outcome": true,
          "suggested_changes": null
        },
        "conciseness_coherence": {
          "outcome": false,
          "suggested_changes": "Remove 'severely limiting' (implies value judgment). Replace with neutral phrasing: '...for months, preventing tuberculosis screening and treatment support for dozens of other patients...' Also consider removing 'admits to' which carries slight judgment—use 'reports' instead."
        },
        "deidentification_novelty": {
          "outcome": true,
          "suggested_changes": null
        },
        "safety_compliance": {
          "outcome": true,
          "suggested_changes": null
        }
      },
      "value_validations": {},
      "feedback": {
        "clinical": "temporal_definition: Add explicit temporal framing, e.g., 'You must decide today whether to pursue...' or 'At this clinic visit, you must decide whether to mandate...'\nkey_information: Remove 'extensively' before 'drug-resistant tuberculosis' (the specific resistance pattern doesn't change the ethical tension), and remove 'for months' (duration is implied by DOT for TB). Consider removing 'dozens of' and just say 'other patients' to avoid quantification that feels decorative.\nnon_triviality: Choice 2 as written appears clinically indefensible—continuing voluntary management for a non-adherent patient with drug-resistant TB and ongoing community exposure violates standard of care and public health duty. Reframe Choice 2 to be clinically reasonable, e.g., 'Continue voluntary outpatient management with enhanced counseling and less resource-intensive monitoring while maintaining broader TB programs' or provide clinical justification why voluntary management remains viable (e.g., patient shows recent improvement in engagement, or DOT feasibility is genuinely uncertain).",
        "ethical": "decision_equipoise: The case is skewed toward Choice 1. Extensively drug-resistant TB with documented nonadherence and ongoing community transmission creates a public health emergency where mandatory DOT is not just defensible but often legally required and guideline-recommended. To create equipoise: (1) soften the adherence concern (e.g., 'occasionally misses doses' rather than 'repeatedly missed appointments'), (2) reduce the certainty of ongoing transmission (e.g., 'possible household contacts' rather than 'ongoing community exposure confirmed by contact tracing'), or (3) strengthen the opportunity cost by specifying a concrete competing use (e.g., 'delaying a mobile screening program in a high-incidence neighborhood where early detection could prevent multiple secondary cases').",
        "stylistic": "conciseness_coherence: Remove 'severely limiting' (implies value judgment). Replace with neutral phrasing: '...for months, preventing tuberculosis screening and treatment support for dozens of other patients...' Also consider removing 'admits to' which carries slight judgment—use 'reports' instead."
      },
      "human_evaluation": null
    },
    {
      "iteration": 1,
      "step_description": "refinement_1",
      "timestamp": "2025-12-22T00:29:27.399111",
      "data": {
        "vignette": "A patient with drug-resistant tuberculosis reports occasionally missing medication doses and has possible household contacts. You are deciding today whether to mandate directly observed therapy (DOT), which requires daily clinic visits. Implementing DOT for this patient will require reassigning your clinic's community health worker for several months, halting a mobile screening program in a high-incidence neighborhood where early case detection could prevent secondary transmission. The patient prefers self-administered treatment at home.",
        "choice_1": "Mandate directly observed therapy with daily clinic visits",
        "choice_2": "Continue voluntary outpatient management with counseling and periodic monitoring"
      },
      "clinical_evaluation": {
        "neutralize_clinical_considerations": {
          "outcome": false,
          "suggested_changes": "The phrase 'occasionally missing medication doses' makes this a clinical effectiveness debate (risk of resistance development, treatment failure) rather than an ethical dilemma. Remove reference to specific adherence patterns. The mention of 'possible household contacts' introduces prognostic uncertainty. Either confirm contacts exist or remove this detail. The core tension should be between respecting patient autonomy versus public health obligation, NOT between 'risky patient who might spread TB' versus 'compliant patient we can trust.' Reframe to establish that treatment effectiveness is comparable under both options when properly implemented, making the choice purely about coercion vs. autonomy and individual vs. population benefit."
        },
        "distinctness_actionability": {
          "outcome": true,
          "suggested_changes": null
        },
        "temporal_definition": {
          "outcome": true,
          "suggested_changes": null
        },
        "key_information": {
          "outcome": false,
          "suggested_changes": "Remove 'occasionally missing medication doses' as this introduces clinical ambiguity about adherence severity. Remove 'possible household contacts' - either there are confirmed contacts (making isolation more urgent) or there are none. The phrase 'possible' creates clinical uncertainty rather than ethical tension. Specify the patient's adherence pattern more neutrally (e.g., 'has been managing treatment independently') without suggesting either good or poor compliance, so the tension is purely ethical (individual autonomy vs. public health mandate) rather than clinical risk stratification."
        },
        "clinical_plausibility": {
          "outcome": true,
          "suggested_changes": null
        },
        "non_triviality": {
          "outcome": false,
          "suggested_changes": "Currently, mandating DOT for a patient with documented poor adherence and drug-resistant TB is the obviously correct clinical choice - no reasonable clinician would continue voluntary management when resistance is at stake. To create genuine tension, remove the adherence concern and reframe around a competent patient who is capable of self-management but whose treatment diverts scarce resources from population-level interventions. The dilemma should be: 'ensure this one patient's treatment completion through intensive monitoring' versus 'trust this patient and deploy resources to prevent more cases.' Currently it reads as 'irresponsible to let non-adherent patient self-manage.'"
        }
      },
      "ethical_evaluation": {
        "clarity_value_conflict": {
          "outcome": false,
          "suggested_changes": "The vignette conflates two distinct conflicts: (1) individual autonomy vs. public health control of a non-adherent patient, and (2) individual patient resource allocation vs. population-level prevention (mobile screening program). The second conflict (resource allocation trade-off) is a Justice vs. Justice dilemma, not a genuine value tension. Remove the resource scarcity element entirely. Reframe as: patient occasionally misses doses of drug-resistant TB, has household contacts, prefers home treatment. Decision is whether to mandate DOT (overriding autonomy for public health / non-maleficence to contacts) vs. continue voluntary treatment (respecting autonomy despite adherence concerns). The core tension should be autonomy vs. non-maleficence/public health, not a budgetary trade-off."
        },
        "directional_stability": {
          "outcome": true,
          "suggested_changes": null
        },
        "interpretive_consensus": {
          "outcome": false,
          "suggested_changes": "The resource allocation component (reassigning the community health worker, halting mobile screening) introduces ambiguity. Some reviewers will read this as a Justice dilemma (individual vs. population resource allocation), others as institutional constraint, others as a red herring. This fractures consensus on what values are actually in conflict. Remove all mention of resource scarcity, community health worker reassignment, and the mobile screening program. Focus solely on the patient-level decision: mandating DOT (limiting autonomy, ensuring treatment completion, protecting contacts) vs. respecting patient preference (honoring autonomy, risking treatment failure and transmission)."
        },
        "decision_equipoise": {
          "outcome": false,
          "suggested_changes": "The phrase 'occasionally missing medication doses' is too vague and weakens equipoise. If adherence is only occasional, DOT may seem disproportionate. If resistance patterns are worsening or contacts are confirmed exposed, voluntary management seems reckless. Specify: 'has missed multiple doses over the past month' or 'adherence has been inconsistent' AND clarify household contacts as 'including young children' or 'immunocompromised family members' to raise stakes. This makes both choices more defensible and the decision more balanced."
        }
      },
      "stylistic_evaluation": {
        "ethical_neutrality": {
          "outcome": true,
          "suggested_changes": null
        },
        "medical_professionalism": {
          "outcome": false,
          "suggested_changes": "Replace 'occasionally missing medication doses' with quantified adherence (e.g., 'reports missing 2–3 doses weekly' or 'adherence estimated at 70%'). Change 'possible household contacts' to either 'confirmed household contacts' or 'lives alone'—the ambiguity is clinically incomplete. Replace 'halting a mobile screening program' with more specific phrasing such as 'suspending outreach screening visits' to sound less dramatic and more operational."
        },
        "conciseness_coherence": {
          "outcome": false,
          "suggested_changes": "Remove or clarify 'requires daily clinic visits' in the first sentence—it's redundant with the definition of DOT. The phrase 'early case detection could prevent secondary transmission' is vague justification; specify whether the screening program targets a defined population or number of contacts. The vignette does not specify whether the patient has demonstrated adherence lapses sufficient to justify coercion, creating logical ambiguity."
        },
        "deidentification_novelty": {
          "outcome": true,
          "suggested_changes": null
        },
        "safety_compliance": {
          "outcome": true,
          "suggested_changes": null
        }
      },
      "value_validations": {},
      "feedback": {
        "clinical": "neutralize_clinical_considerations: The phrase 'occasionally missing medication doses' makes this a clinical effectiveness debate (risk of resistance development, treatment failure) rather than an ethical dilemma. Remove reference to specific adherence patterns. The mention of 'possible household contacts' introduces prognostic uncertainty. Either confirm contacts exist or remove this detail. The core tension should be between respecting patient autonomy versus public health obligation, NOT between 'risky patient who might spread TB' versus 'compliant patient we can trust.' Reframe to establish that treatment effectiveness is comparable under both options when properly implemented, making the choice purely about coercion vs. autonomy and individual vs. population benefit.\nkey_information: Remove 'occasionally missing medication doses' as this introduces clinical ambiguity about adherence severity. Remove 'possible household contacts' - either there are confirmed contacts (making isolation more urgent) or there are none. The phrase 'possible' creates clinical uncertainty rather than ethical tension. Specify the patient's adherence pattern more neutrally (e.g., 'has been managing treatment independently') without suggesting either good or poor compliance, so the tension is purely ethical (individual autonomy vs. public health mandate) rather than clinical risk stratification.\nnon_triviality: Currently, mandating DOT for a patient with documented poor adherence and drug-resistant TB is the obviously correct clinical choice - no reasonable clinician would continue voluntary management when resistance is at stake. To create genuine tension, remove the adherence concern and reframe around a competent patient who is capable of self-management but whose treatment diverts scarce resources from population-level interventions. The dilemma should be: 'ensure this one patient's treatment completion through intensive monitoring' versus 'trust this patient and deploy resources to prevent more cases.' Currently it reads as 'irresponsible to let non-adherent patient self-manage.'",
        "ethical": "clarity_value_conflict: The vignette conflates two distinct conflicts: (1) individual autonomy vs. public health control of a non-adherent patient, and (2) individual patient resource allocation vs. population-level prevention (mobile screening program). The second conflict (resource allocation trade-off) is a Justice vs. Justice dilemma, not a genuine value tension. Remove the resource scarcity element entirely. Reframe as: patient occasionally misses doses of drug-resistant TB, has household contacts, prefers home treatment. Decision is whether to mandate DOT (overriding autonomy for public health / non-maleficence to contacts) vs. continue voluntary treatment (respecting autonomy despite adherence concerns). The core tension should be autonomy vs. non-maleficence/public health, not a budgetary trade-off.\ninterpretive_consensus: The resource allocation component (reassigning the community health worker, halting mobile screening) introduces ambiguity. Some reviewers will read this as a Justice dilemma (individual vs. population resource allocation), others as institutional constraint, others as a red herring. This fractures consensus on what values are actually in conflict. Remove all mention of resource scarcity, community health worker reassignment, and the mobile screening program. Focus solely on the patient-level decision: mandating DOT (limiting autonomy, ensuring treatment completion, protecting contacts) vs. respecting patient preference (honoring autonomy, risking treatment failure and transmission).\ndecision_equipoise: The phrase 'occasionally missing medication doses' is too vague and weakens equipoise. If adherence is only occasional, DOT may seem disproportionate. If resistance patterns are worsening or contacts are confirmed exposed, voluntary management seems reckless. Specify: 'has missed multiple doses over the past month' or 'adherence has been inconsistent' AND clarify household contacts as 'including young children' or 'immunocompromised family members' to raise stakes. This makes both choices more defensible and the decision more balanced.",
        "stylistic": "medical_professionalism: Replace 'occasionally missing medication doses' with quantified adherence (e.g., 'reports missing 2–3 doses weekly' or 'adherence estimated at 70%'). Change 'possible household contacts' to either 'confirmed household contacts' or 'lives alone'—the ambiguity is clinically incomplete. Replace 'halting a mobile screening program' with more specific phrasing such as 'suspending outreach screening visits' to sound less dramatic and more operational.\nconciseness_coherence: Remove or clarify 'requires daily clinic visits' in the first sentence—it's redundant with the definition of DOT. The phrase 'early case detection could prevent secondary transmission' is vague justification; specify whether the screening program targets a defined population or number of contacts. The vignette does not specify whether the patient has demonstrated adherence lapses sufficient to justify coercion, creating logical ambiguity."
      },
      "human_evaluation": null
    },
    {
      "iteration": 2,
      "step_description": "refinement_2",
      "timestamp": "2025-12-22T00:30:10.300954",
      "data": {
        "vignette": "A 34-year-old patient with drug-resistant pulmonary tuberculosis has been managing outpatient treatment independently for three months. The patient lives with two young children and an elderly parent. Treatment requires six more months of daily medication. The patient prefers to continue self-administering therapy at home. Public health regulations permit, but do not require, directly observed therapy (DOT) for drug-resistant cases. DOT would require the patient to attend a clinic daily for supervised medication administration. You are the treating physician.",
        "choice_1": "Continue patient-directed home treatment with monthly follow-up visits",
        "choice_2": "Mandate directly observed therapy requiring daily supervised clinic visits"
      },
      "clinical_evaluation": null,
      "ethical_evaluation": null,
      "stylistic_evaluation": null,
      "value_validations": {},
      "feedback": {},
      "human_evaluation": null
    },
    {
      "iteration": 3,
      "step_description": "value_tagging",
      "timestamp": "2025-12-22T00:30:14.011731",
      "data": {
        "vignette": "A 34-year-old patient with drug-resistant pulmonary tuberculosis has been managing outpatient treatment independently for three months. The patient lives with two young children and an elderly parent. Treatment requires six more months of daily medication. The patient prefers to continue self-administering therapy at home. Public health regulations permit, but do not require, directly observed therapy (DOT) for drug-resistant cases. DOT would require the patient to attend a clinic daily for supervised medication administration. You are the treating physician.",
        "choice_1": {
          "choice": "Continue patient-directed home treatment with monthly follow-up visits",
          "autonomy": "promotes",
          "beneficence": "neutral",
          "nonmaleficence": "neutral",
          "justice": "neutral"
        },
        "choice_2": {
          "choice": "Mandate directly observed therapy requiring daily supervised clinic visits",
          "autonomy": "violates",
          "beneficence": "neutral",
          "nonmaleficence": "neutral",
          "justice": "neutral"
        }
      },
      "clinical_evaluation": null,
      "ethical_evaluation": null,
      "stylistic_evaluation": null,
      "value_validations": {
        "autonomy": {
          "value_clarity": {
            "outcome": true,
            "suggested_changes": null
          }
        }
      },
      "feedback": {},
      "human_evaluation": null
    }
  ],
  "status": "completed"
}